fbpx

COVID-19

Articles and publications written by the CCC about the COVID-19 Coronavirus Pandemic.

The folly of opposing patents on a Covid vaccine

Doctors Without Borders does incredible work in the interest of patients around the globe. It has an exemplary track record of bringing doctors to the front lines of combat zones, famines, and pandemics — helping those patients that are left alone and victims of large crises.

During the 2014-2015 Ebola epidemic in West Africa, MSF (to use its French acronym) was the leading organisation fighting for patients — far more so than the World Health Organization, which is bureaucratic and has slow response times. For that and its previous 48 years of service, it needs to be applauded.

However, its current opposition to patents on drugs treating Covid-19 misunderstands the importance of intellectual property rights for medical innovation.

MSF is also running a campaign on access to medicines which distorts the realities of the drug market, while calling for solutions that would harm scientific innovation. The “Campaign for Access to Essential Medicines” wants to increase the availability of medicines in developing nations by addressing drug pricing and intellectual property rights. In the eyes of MSF, producers and researchers are enriching themselves off the backs of those who can least afford it.

What MSF gets wrong is that intellectual property rights and patents do not hinder innovation but actually enable medical progress.

Dozens of pharmaceutical companies have not only started searching for a vaccine against Covid-19 but have also thrown a lot of resources into getting millions of tests produced, looking at what existing drugs might be able to treat the disease, and donating money and materials to health systems across the world.

In fact, the philanthropic efforts of pharmaceutical companies are impressively underreported. By any standard, these companies are offering charitable support, including to organisations working with patients on the ground. However, Doctors Without Borders has said that it will not accept in-kind donations of drugs from pharmaceutical companies, but instead purchase them at market prices. Donors to MSF would probably be stunned by the idea that their donations are spent on drugs that MSF could have got for free.

While the industry also cares about access a lot, dysfunctional health systems and infrastructure are often the barrier between a patient and a treatment or vaccine. We need to realise that charitable acts are only possible if profits are also encouraged. Pharmaceutical companies develop drugs, protect their inventions and make profits. If you cut out patent rights from the equation, the incentive to innovate disappears, and life-saving medicines that cost billions to develop will stay off the market.

Doctors without Borders calls for preventing drug profiteering on the novel coronavirus, while ignoring the significant donations being made to help stop this virus. In fact, most efforts to combat the disease are public-private partnerships, much like the fight against Ebola was.

Remember too that stopping companies making a profit from drugs both eliminates incentives and ignores both the risks and the costs of working on a new drug. Who are we to tell lab workers to come into work every day for free, when there are risks associated with going to work and interacting with fellow employees?

The idea of so-called compulsory licenses, which de facto takes a patent away from a manufacturer in one country and gives it to another, might even delay the introduction of a Covid-19 vaccine even more. It takes know how and supply chains to manufacture and deliver a working vaccine. It is questionable whether a vaccine produced under compulsory licensing would actually be less expensive than the original one.

Much can be said about drug manufacturing and access to essential medicines. But a proper debate needs to be held on the basis of certain basic facts. Among these is that pharmaceutical companies invest vast sums of money to provide life-saving medicines, and those same companies have also taken action to help those in the most need. With Covid-19, we are facing one of the biggest public health crises ever – Innovation and medical breakthroughs are needed now more than ever. Undermining the ownership of innovations will definitely not lead to the breakthroughs that will ultimately get us out of this nightmare.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

“Die Schuldigen nicht in den Skihütten von Ischgl suchen”

Die weltweite Verbraucherorganisation Consumer Choice Center nimmt die Gastwirte im österreichischen Party-Hotspot in Schutz.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

The Covid-19 Response isn’t a Vindication for Socialism

The pandemic is not a crisis of capitalism, if anything it proves we will need free markets more than ever before, argues Joey Simnett

National emergencies are a breeding ground for those who claim it confirms their worldview, who use them to push their own agenda long after the crisis passes. And now, during Covid-19, they once again slither out of the woodwork.

There has been no shortage of state apologists who feel vindicated by this unprecedented event, and wish to keep it this way. Once again our decadent individualist culture and corrupt capitalist system have apparently failed us, and now big government has stepped in to save the day.

BBC Newsnight described Chancellor Rishi Sunak’s rescue package as “embracing Keynesianism”. Professor Mariana Mazzucato posited that we should use this crisis to “think about capitalism differently”, and recent resignee Jeremy Corbyn had a “told you so” moment where he stated he was “right” about public spending.

But this commentary on the government’s countermeasures fundamentally misses the point and the nature of the program.

What has happened with Covid-19 is a truly exogenous (i.e. non-economic) supply side shock. In fact, it behoves the government to actively and explicitly “freeze” the labour force until the crisis passes. And, until it does, it is imperative to maintain the intricate web of market relations that form the economy, as this crisis is not a result of them being inherently rotten.

There is no “crisis of capitalism” or traditional economic recession here; there have been no bad investments, malignant animal spirits, or popped bubbles. There is no need to “right the wrongs of the market” like Keynesians and socialists desire to do, nor has the Chancellor done so.

This is simply a case of governments spending money, as governments of all stripes do. But the key distinction lies in when, how, and why they do so.

The highlight of the Chancellor’s plan is to pay a portion of people’s wages for a period of time. Direct cash transfers are some of the most economically neutral interventions a government can perform. It does not remotely resemble the kind of top-down Soviet economic planning or the grotesque market distortions we’ve witnessed both preceding and proceeding economic crashes.

But, the critics say, we do see mass mobilisation in the production and acquisition of medical equipment under Matt Hancock—surely this demonstrates the effectiveness of government-led planning?

It does in one respect, in the same way conscription was necessary in World War II. But this does not mean it’s a good idea in day-to-day life. Governance involves learning, choices, and trade-offs, which means we shouldn’t forever sit in our bunkers with a rifle aimed at the door in anticipation of all manner of hypothetical events.

Who wants to see our dear comrades at the Department for Environment, Food and Rural Affairs decide who produces our food, how much food to produce, and who to give it to on an on-going basis—one brief glimpse at Maoist China suggests that governments are simply incapable of managing such complex and ever-changing economic processes.

But while there’s nothing inherently revolutionary about how our government is functioning, there’s certainly a risk that it could be as soon as Covid-19 is out of the picture.

The horrors of World War II didn’t stop after the flattening of Nagasaki. Rather, an ideological battle emerged between those who wished to return to normalcy, and those who saw merit in a state-led society. It was the darlings of 20th century progressivism, the Attlee government, who pushed to make food rationing and identity cards a permanent feature in day-to-day life.

In fact, it would take nine whole years to finally lay them to rest under Churchill’s second shot as Prime Minister.

Sunak stated that “this is not a time for ideology or orthodoxy”, but given the dramatic shift to the left in both the Conservative and Labour parties in recent years, it may well be once we are all fit and healthy again.

Author: Joey Simnett is a UK policy fellow at the Consumer Choice Center, and has previously written for American physicians on the US healthcare system, and on fiat alternatives in the payments world

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Après le coronavirus, faisons des améliorations à notre cadre législatif

Après des semaines de changements à notre façon de consommer, nous voyons qu’il y a des améliorations importantes à faire, en ce qui concerne nos chaînes d’approvisionnement et les moyens disponibles pour se procurer des produits et services. Profitons de cette phase de lucidité pour faire des changements appropriés.

Plusieurs semaines de confinement nous montrent que tout ne s’est pas
déplacé sur internet et qu’une présence physique est difficilement remplaçable avec une connexion internet. Tout de même, nous voyons aussi qu’il y a raison de se réjouir du fait que cette pandémie nous tombe dessus en 2020 et pas il y a vingt ans. Nous avons la possibilité de rechercher et commander des produits et services, presque sans
aucune nécessité de se déplacer.

Les outils de travail à distance tels que Zoom, Asana ou les outils de Google ont déjà révolutionné le monde du travail. La plupart des réunions peuvent
être converties en appel vidéo. Dans des pays comme le Royaume-Uni, les consommateurs peuvent dire que grâce à des services de livraison de produits alimentaires tels que Amazon Fresh etOcado, nous pouvons constituer une bonne quantité de réserves de conserves, de produits secs et de produits pour la salle de bains, sans même avoir à nous battre pour les
derniers produits dans certains supermarchés presque vides.

Au Luxembourg, où ces services n’existent pas, la question se pose si notre cadre réglementaire n’est pas à l’origine de ce défaut. L’absence de services comme Uber, ou les trottinettes électriques comme Bird, nous indique qu’une législation fautive est à l’origine de cette défaillance. Tant que des villes comme Bruxelles ou Paris bénéficie de l’économie de partage, les restaurateurs et la clientèle luxembour- geoises doivent se contenter de sites web incomplets de restau- rants, et l’HORESCA qui organise un service de livraison à 10 euros par commande (pour ceux qui n’ont pas de service intégré de livraison).

Il s’avère que les applications décentralisées sont mieux préparées pour faire face à des crises et la demande des clients. Un grand changement dans l’approvisionnement de produits et services est celui des médicaments et des services médicaux. Pendant la pandémie, nous voyons l’arrivée des télé-consultations, dont on espère qu’elles ne resteront pas une innovation temporaire. Afin de récupérer leurs ordonnances, les patients ont dû se déplacer en pharmacies — une obligation superflue.

Huit pays dans l’Union européenne donnent le droit à leurs citoyens de commander des médicaments sur ordonnance en ligne : le Royaume-Uni, l’Allemagne, la Suisse, les Pays-Bas, le Danemark, la Suède, la Finlande et l’Estonie. Au Luxembourg, le gouvernement nous informe que “Seuls les médicaments sans ordonnance peuvent être vendus sur internet. Il n’est pas prévu d’autoriser la vente à distance de médicaments sur ordonnance.” Espérons que la crise actuelle donnera la motivation nécessaire aux parlementaires de s’intéresser à une légalisation de ces services.

Au niveau de l’Agence européenne des médicaments (EMA), nous aurions besoin d’un audit pour comprendre pourquoi un fast-tracking des procé-
dures d’approbation n’a pas encore été possible. Dans une situation d’urgence comme celle du coronavirus, il nous faut des recherches efficaces, et une bureau- cratie qui autorise au plus vite les médicaments nécessaires. L’Agence luxembourgeoise des médicaments et des produits de santé (ALMPS) devra fonctionner d’après les mêmes principes : mettre la priorité pour maximiser le nombre de nouveaux médicaments sûrs, en réduisant les obstacles administratifs. En même temps, le Luxembourg doit aussi autoriser et encourager le “droit à l’essai” médical. La loi sur le droit d’essayer ou loi Trickett Wendler, Frank Mongiello, Jordan McLinn et Matthew Bellina, a été promulguée le 30 mai 2018 aux États-Unis. Cette loi est un autre moyen pour les patients chez qui on a diagnostiqué des maladies mortelles, qui ont essayé toutes les options de traitement approuvées et qui ne peuvent pas participer à un essai clinique, d’accéder à certains traitements non approuvés. Les essais cliniques permettent de savoir si un produit est sûr à l’emploi et peut traiter ou prévenir efficacement une maladie. Les personnes peuvent avoir de nom-
breuses raisons de participer à des essais cliniques.

En plus de contribuer aux connaissances médicales, certaines personnes participent à des essais cliniques parce qu’il n’existe aucun traitement pour leur maladie, que les traitements qu’elles ont essayés n’ont pas fonctionné ou qu’elles ne sont pas en mesure de tolérer les traitements actuels.

Au-delà, il faut aussi plus de cybersécurité chez les Luxembourgeois et les entreprises contre les cyberattaques qui se propagent lors de cette pandémie. La sécurité du réseau doit être garantie pour garder l’at-
tractivité de la place financière – pour ce faire, une exclusion de certains acteurs du marché de télécommunication, dont la Chine, ne doit pas être exclue. Et qui dit vie privé, doit aussi garantir une révision de la
Constitution qui met en évidence les idées reçues de cette crise, afin de prévenir encore plus les abus de pouvoir dans des urgences futures.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Five measures that could prevent future lockdowns

That the World Health Organisation hasn’t exactly shone in the coronavirus crisis is now well-documented. It should remind us of the dangers of following one centrally-guided approach to tackling the disease. Thankfully, given how even experts have been unsure about how to respond to this enormous challenge, there was no unified EU response to Covid-19. Instead, European countries have been dealing with the virus using trial and error.

As a result, looking at the responses of European and Asian countries, we can now distinguish five important things that seem to have worked to prevent the need for a strict, economically devastating lockdown.

Read more here


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Overreaching Lockdowns Are Flattening Our Livelihoods

Millions of Americans are in the penalty box as we speak.

They have followed the advice of state and local officials and they have stayed home to stop the spread of COVID-19.

Businesses are on hold, birthdays are canceled, travel is limited, and we are glued to our screens to see how this all ends. While some of us have been able to carry on work, essential or not, during this trying time, that’s just not possible for most.

More than 16 million Americans have filed for unemployment benefits since lockdown orders went into effect in mid-March, and economists say we could face as high as 20 percent unemployment by summer.

It is certainly true that many states and cities have saved lives by ordering us to stay home. But blanket lockdowns are now flattening our livelihoods in a way that’s more dangerous than this pandemic.

Danish political scientist Bjorn Lomborg says that by closing all schools and jobs, we are “actually creating more damage, more long-term death, more long-term unemployment and unpleasantness for the whole population compared to what you’re achieving in saving lives.”

He’s right. It’s why Austria and Denmark have already begun to relax their lockdowns and open up their economies, but with social distancing rules still in effect. European leaders see the real damage that has been done to societies, and it is time to turn the tide while remaining responsible.

That is exactly what the American people can do as well.

We can still be responsible by socially distancing where necessary, wearing facemasks, quarantining at-risk groups, and using technology to track the spread of the virus. That is what countries going back to work have done since the start.

That will be more effective than forcing businesses to shutter, driving many of our compatriots to foodbanks or the brink of homelessness.

We have to look no further than our own hospitals.

It is true that many health facilities in major cities are overwhelmed, and we should be sending them every resource where possible.

But by canceling elective surgeries and operations that feed their budgets, rural and county hospitals have ironically begun laying off hundreds of thousands of health professionals and administrative staff. This is not because they are overwhelmed with COVID-19 patients but rather because they do not have any patients at all.

If we are losing health professionals during a pandemic, then we are doing something wrong.

A one-size-fits-all-approach is usually misguided in our federal system, and it’s wrong now. There are 27 states that have had less than 100 fatalities, yet are still imposing crushing lockdowns. It is no wonder so many are itching to get back to work.

It is time to admit lockdowns are not a universal answer to the crisis we face.

Many criticize President Trump for his desire to open up the American economy. But his anxiety is a signal to workers and entrepreneurs everywhere: the pain and suffering of the novel coronavirus are real, but losing your income and prospects for feeding your family is just as bad or sometimes even worse.

Americans are a robust, strong and resilient people. We understand that things may never be the same, but we should be trusted to continue our lives while following the guidance of our scientists and doctors. That is the balance we need to protect our livelihoods and save those most vulnerable.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Scroll to top
en_USEN